Pharmaceutical Technology

MARCH 12, 2024

Butterworth Laboratories looks at the current amino acid testing landscape since the changes in monographs introduced in 2013.

52

52

Clarivate

JUNE 27, 2024

From just 39 publications in 2013, the number soared nearly 70-fold to 2,641 in 2022, totaling 7,944 over the decade. From 93 papers in 2013, the publication pool expanded to 7,662 papers by 2022. Data source: Web of Science, Clarivate).

Healthcare 80

Healthcare Healthcare Government Education 80

MedCity News

OCTOBER 17, 2022

It’s the second partnership between the two companies; an alliance that began in 2013 expired without Gilead licensing any molecules from the deal. Gilead Sciences is betting that a MacroGenics antibody drug for blood cancers can offer a safety edge over others that address the same target.

Safety 84

Safety Biopharma Pharma 84

World of DTC Marketing

MAY 26, 2021

AbbVie has also raised the price of Imbruvica by 82% since launching the drug in 2013. For a patient taking 3 tablets daily, the annual net price of Imbruvica increased from $72,587 in 2013 to $115,533 in 2017 (the last year for which AbbVie provided the Committee data). billion in 2013—the year it separated from Abbott—to $16.1

Competition 180

Competition Marketing Government Patients 180

Pharmacy Times

DECEMBER 4, 2023

in 2013 to 19.3% The proportion of prescriptions by a 340B-affiliated physician increased from 9.4% in 2020, but the prescriptions filled by 340B pharmacies increased from 18.4% to 49.9%.

Prescription 48

Prescription Physicians 48

PharmExec

JULY 7, 2022

In episode 112, Nima Farzan, CEO of Kinnate, who was one of Pharmaceutical Executive’s Emerging Pharma Leaders in 2013, discusses how he’s successfully navigated his career path, from building a foundation in pharma to growing his expertise in biotech.

Pharma 52

Pharma Pharmaceutical 52

Clarivate

SEPTEMBER 7, 2023

Figure 2: Impact – The citation impact (measured by Category Normalized Citation Impact, or CNCI) of the papers published by each country/region, presented in both an Impact Profile and the trend for 2013-2022. Figure 3: Output – Trends in international output and open access output for 2013-2022 for each G20 member nation.

Government 116

Government Education Medicine Medical 116

European Pharmaceutical Review

JUNE 28, 2024

The Novartis-MIT project culminated in a 2013 publication describing an end-to-end continuous process to produce aliskiren drug substance, and formulated drug product, at pilot scale. For pharmaceuticals, the motivating factors likely include the desire for greater quality control, along with expected improvements in safety and efficiency.

Manufacturing 52

Manufacturing Safety Pharmaceutical 52

Pharmacy Times

MARCH 11, 2024

The early phase clinical trial, which ended prematurely in 2013 due to funding challenges, further illustrates disparities in health equity in clinical research.

20

20

World of DTC Marketing

OCTOBER 6, 2021

The Defense Threat Reduction Agency, a division of the Department of Defense, provided more than $10 million of funding in 2013 and 2015 to Emory University, as research done by the nonprofit Knowledge Ecology International has revealed.

Food and Drug Administration 198

Food and Drug Administration Government Medicine Food 198

World of DTC Marketing

MAY 5, 2021

In 2013 she threw in her lot with BioNTech. The basic mRNA technology was primarily developed by Katalin Karikó and Drew Weissman when both worked at the U of Pennsylvania, where higher-ups dismissed Karikó as deadwood unworthy of university support. And how did Pfizer reward this partnership?

Government 281

Government Distribution Manufacturing Sales 281

World of DTC Marketing

FEBRUARY 17, 2022

Moreover, localized lung cance r diagnoses rose to 28% in 2018 from 20% in 2013— the year that the U.S. The 5-year survival rate has increased by 6% for distant-stage lung cancer, 33% for a regional-stage disease, and 60% for localized disease.

Medicine 271

Medicine Insurance Leads Medical 271

European Pharmaceutical Review

JULY 5, 2023

Having been originally published in 2007, then revised in 2013, this latest 2023 edition addresses evolving standards and container types.

Manufacturing 96

Manufacturing Pharmaceutical manufacturing Pharmaceutical products Pharmaceutical 96

World of DTC Marketing

NOVEMBER 24, 2021

One-quarter of all cancer patients chose not to fill a prescription due to cost, according to a 2013 study in The Oncologist. According to a study published in the American Journal of Medicine, more than 42 percent of the 9.5 million people diagnosed with cancer from 2000 to 2012 drained their life’s assets within two years.

Food and Drug Administration 266

Food and Drug Administration Insurance Prescription FDA 266

Clarivate

JANUARY 23, 2024

Figure 1 illustrates the trend in the number of NMEs first launched onto the world market between 2013 and 2022. In fact, the number of NMEs has grown by 65% between 2013 and 2022. Looking at NMEs launched globally in 2022 paints a gloomy picture at first sight, with a 28% drop from 2021 to 2022.

Pharma 52

Pharma Sales Consulting Pharmaceutical 52

PM360

SEPTEMBER 20, 2024

To see all this years Winners please visit: [link] For more information and sponsorship opportunities: Peter Beattie, Awards Director: awards@thecreativefloor.com About The Creative Floor The Creative Floor Healthcare Awards was founded in 2013 by Shaheed Peera. The aim was to help change the way award shows are run.

Healthcare 52

Healthcare Healthcare Specialization Networking 52

European Pharmaceutical Review

MARCH 11, 2024

An earlier case of contamination from 2013 of manufactured steroid injections containing methylprednisolone acetate was also mentioned in the paper. The authors stated that the presence of Aspergillus penicillioides in antimicrobial preoperative skin preparation drugs were attributed to inadequate storage conditions.

Pharmaceutical 98

Pharmaceutical Food and Drug Administration Manufacturing Pharmaceutical products 98

Pharmaceutical Technology

MARCH 27, 2023

During 2013–2022, NME approvals were lower only in 2013 and 2016. The drop in these new molecular entities (NMEs), both small molecules and biologics, resulted in fewer commercial-scale production contracts for the most innovative CMOs.

Manufacturing 52

Manufacturing FDA Marketing Pharmaceutical 52

European Pharmaceutical Review

JULY 28, 2023

Since 2013, Barr has worked as Senior Vice President, Head of Research and Product Development of Alexion, AstraZeneca’s rare disease group. She will work across Cardiovascular, Renal & Metabolism and Respiratory & Immunology.

Medicine 98

Medicine Patients Pharma Pharmaceutical 98

European Pharmaceutical Review

SEPTEMBER 26, 2022

Construction at the Carrigtwohill facility built in 2013 is set to begin in 2023. AbbVie , an international R&D biopharmaceutical enterprise has celebrated its 20th anniversary by investing in extensive renovations at its manufacturing site in Cork, Ireland.

Manufacturing 98

Manufacturing Pharmaceutical manufacturing Biopharma Engineering 98

World of DTC Marketing

SEPTEMBER 7, 2022

household income from 2009 to 2013 was $53,046, according to the United States Census Bureau, but many of the most recently approved anticancer treatments approved by the United States Food and Drug Administration (FDA) are priced well above $100,000 per year. ASH Clinical News takes it a step further.

Pharma 210

Pharma Food and Drug Administration Marketing Prescription 210

European Pharmaceutical Review

AUGUST 30, 2022

The report, Clinical Trials – The Importance of Diversity in Clinical Trials , examined data from clinical trials initiated between 1 January 2013 and 16 June 2022. Diversity within the pharmaceutical sector and clinical trials continues to be a problem, according to a recent report by data and analytics company GlobalData.

Food and Drug Administration 97

Food and Drug Administration Food Safety Pharmaceutical 97

World of DTC Marketing

AUGUST 9, 2021

HCPs are also connecting more than ever: one study showed that HCP posts about healthcare increased from 10% in 2013 to 50% in 2019. According to Sermo, two-thirds of physicians spend at least an hour on social media, with an average daily use of two hours and twenty-two minutes. 33 Even now, nearly 70% of all HCPs are digital natives.

Media 294

Media Physicians Pharma Marketing 294

European Pharmaceutical Review

NOVEMBER 2, 2023

The most recent guide was published by the WHO in 2013. The study, which was funded by the Wellcome Trust, also reveals the urgent need for global antibiotic guidelines to be updated, to reflect the rapidly evolving rates of AMR. The WHO has declared AMR as one of the top 10 global public health threats facing humanity.

Manufacturing 98

Manufacturing Leads Medical Pharmaceutical 98

World of DTC Marketing

AUGUST 19, 2022

A Journal of the American Medical Association ( JAMA ) study investigated how five key factors were associated with healthcare increases from 1996 to 2013: Service price and intensity Population growth Population aging Disease prevalence or incidence Medical service utilization.

Healthcare 204

Healthcare Healthcare Insurance Competition 204

World of DTC Marketing

MARCH 28, 2021

However, despite the momentum the bill has gained throughout the years, the Treat and Reduce Obesity Act (commonly known as TROA) has yet to come up for a committee or floor vote since it was first introduced in 2013. It needs to be passed NOW but even this won’t be enough.

Doctors 250

Doctors Patients Insurance Physicians 250

pharmaphorum

DECEMBER 12, 2022

He rose to the position of head of global product strategy at Roche in 2013, before taking the CEO role at Genentech in 2017 and then group head pharma in January 2019. There’s no word yet on where Anderson will continue his career, but a CEO role at a biotech company seems a likely destination.

Pharma 74

Pharma Management Pharmaceutical Marketing 74

PM360

MAY 15, 2023

Classified as a rare disease back in 2013, it’s estimated only one to two people per million suffer from it around the globe. Don Abramo Executive Director, Leniolisib Marketing Pharming Healthcare Inc. A Truly Rare Marketer Activated PI3K delta syndrome (APDS) is a recently discovered rare disease that really puts the rare in rare.

Healthcare 59

Healthcare Healthcare Physicians Media 59

pharmaphorum

SEPTEMBER 13, 2022

Chiesi’s involvement with Lamzede dates back to 2013, when it acquired the drug’s original developer Zymenex and used it as the foundation for a protein-based therapeutics division. At the moment, almost three quarters of the Italian drugmaker’s turnover is in Europe, with 15% from the US and 13% from the rest of the world.

FDA 102

FDA Distribution Prospecting Patients 102

World of DTC Marketing

MAY 19, 2021

billion on R&D from 2013 to 2018. In January, Fortune reported AbbVie would raise the price of Humira by 7.4%. Why the increase? Drugmakers often claim higher prices are needed to fund research and development. AbbVie spent a total of $2.45 Porter (D-Calif.) pointed out that the company spends nearly double that—$4.7

Pharma 181

Pharma Prescription Patients Pharmaceutical 181

pharmaphorum

APRIL 10, 2017

Indeed, QuintilesIMS forecasts that, between 2013 and 2018, 94% of list price value growth will be in specialty medicines – with orphan drugs at the forefront of this trend.

Medicine 52

Medicine Pharmaceutical Marketing Patients 52

World of DTC Marketing

JUNE 4, 2021

” Roughly 40% of all US cases of incident diabetes during 2013-2016 were directly attributable to obesity , a finding that further solidifies the major etiologic role for obesity in the current American diabetes epidemic. Fewer than 10 percent of American adults ate enough vegetables in 2013. Dr. Natalie A.

Food 207

Food Insurance Leads Medical 207

Pharmaceutical Technology

MAY 25, 2023

The 100,000 Genomes Project was initially announced in December 2012, with Genomics England being launched later in July 2013. Genomics England’s first initiative was the 100,000 Genomes Project, which involved the sequencing of 100,000 genomes from roughly 85,000 National Health Service (NHS) patients with cancer or a rare disease.

Side effects 52

Side effects Medicine Recruitment Doctors 52

Contrarian Sales Techniques

DECEMBER 14, 2022

He became the company's chief marketing officer in 2013. Last week, Tecentriq, a Roche immuno-oncology drug, failed in a phase 3 trial for patients with advanced lung cancer. This was another setback for the company's multiple cancer drug combinations. Anderson joined Genentech in 2006.

Sales 52

Sales Pharmaceutical Marketing Patients 52

European Pharmaceutical Review

JULY 12, 2022

More than 480 warning letters solely related to the failure to produce aseptic conditions because of deficient cleaning and disinfection systems for cleanrooms and their equipment, were issued by regulators between 2013 to 2018. Microbial resistance is one of the factors responsible for such failings.

Pharmaceutical manufacturing 111

Pharmaceutical manufacturing Pharmaceutical Pharmaceutical research Manufacturing 111

Pharmaceutical Technology

OCTOBER 27, 2022

In 2013, the research firm recorded 130 VC deals in the medtech space, valued at a combined $1.047bn. .” The AMPLY deal is the latest in a long line of medtech-related deals throughout the last decade. This has increased dramatically in the last nine years.

Marketing 59

Marketing Medicine Medical Pharmaceutical 59

European Pharmaceutical Review

FEBRUARY 1, 2024

For at least a decade from 2013 until recently, LDL lowering treatments were stuck on a paradigm of just putting people on statins and not getting LDL levels down to certain goals” CETP inhibitors have been around for a while, but they have unfortunately been unsuccessful in getting onto the market commercially. “For

Pharma 97

Pharma Patients Pharmaceutical Leads 97